Tower Research Capital »

Intensity Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $12k 2.4k 4.94
2024-03-31 $38k 7.0k 5.33
2023-09-30 $4.3k 1.0k 4.18

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Intensity Therapeutics

Sapient Capital
Vanguard Group
Brown Advisory Holdings Incorporated
Geode Capital Management
Sigma Planning
Mesirow Financial Investment Management International Equity
William Blair $ Company
One Charles Private Wealth Services
BlackRock
Lakeview Capital Partners
State Street Corporation
BlackRock
Commonwealth Equity Services
Wells Fargo & Company
Tower Research Capital

View all funds holding Intensity Therapeutics